NDC 50090-3483

Trulicity

Dulaglutide

Trulicity is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Dulaglutide.

• Product ID: 50090-3483_4b0fc2d3-dd98-43f2-b5a1-ad66a07ebaaa
• NDC: 50090-3483
• Product Type: Human Prescription Drug
• Proprietary Name: Trulicity
• Generic Name: Dulaglutide
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2014-09-18
• Marketing Category: BLA / BLA
• Application Number: BLA125469
• Labeler Name: A-S Medication Solutions
• Substance Name: DULAGLUTIDE
• Active Ingredient Strength: 2 mg/.5mL
• Pharm Classes: GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [CS],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 50090-3483-0

4 SYRINGE in 1 CARTON (50090-3483-0) > .5 mL in 1 SYRINGE

• Marketing Start Date: 2018-06-18
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 50090-3483-0 [50090348300]

Trulicity INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA125469
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-06-18
• Marketing End Date: 2019-11-30

Drug Details

Active Ingredients

Ingredient	Strength
DULAGLUTIDE	1.5 mg/.5mL

OpenFDA Data

• SPL SET ID: 58353438-3236-4596-9324-62fed9615cb7
• Manufacturer:
  • A-S Medication Solutions
• UNII:
  • WTT295HSY5
• RxNorm Concept Unique ID - RxCUI:
  • 1551300
  • 1551295
  • 1551304
  • 1551306

Pharmacological Class

• GLP-1 Receptor Agonist [EPC]
• Glucagon-Like Peptide 1 [CS]
• Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

NDC Crossover Matching brand name "Trulicity" or generic name "Dulaglutide"

NDC	Brand Name	Generic Name
0002-1433	Trulicity	Dulaglutide
0002-1434	Trulicity	Dulaglutide
0002-2236	Trulicity	Dulaglutide
0002-3182	Trulicity	Dulaglutide
50090-3483	Trulicity	Dulaglutide
50090-3484	Trulicity	Trulicity